Non Hodgkin Lymphoma Clinical Trial

Clinical Trial Finder Non Hodgkin Lymphoma Trials

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

See Locations Near You

Summary

The purpose of this study is to evaluate inotuzumab ozogamicin in combination with rituximab prior to an autologous stem cell transplant (aSCT) in patients with relapsed/refractory diffuse large B-cell Non-Hodgkin's lymphoma.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

CD20/CD22-positive diffuse large B-cell NHL that has relapsed after 1 or 2 prior therapies; one prior therapy must include anthracyclines and one must include rituximab in combination with chemotherapy
Relapsed/disease progression within 12 months after start of prior therapy and/or secondary International Prognostic Index (sIPI) score greater than 1
Eligible for autologous stem cell transplant (aSCT)

Exclusion Criteria:

Prior allogeneic hematopoietic stem cell transplant
Within 6 months prior to test article: autologous transplant, treatment with anti-CD22 antibodies, radio-immunotherapy
Veno-occlusive disease or sinusoidal obstruction syndrome, chronic liver disease, systemic vasculitides, current or chronic hepatitis B or C infection

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 2

Estimated Enrollment:

64

Study ID:

NCT00867087

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 26 Locations for this study

See Locations Near You

Loyola University Medical Center, Foster G. McGraw Hospital and Satellites
Maywood Illinois, 60153, United States
Tufts Medical Center
Boston Massachusetts, 02111, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor Michigan, 48109, United States
Barnes-Jewish Hospital
Saint Louis Missouri, 63110, United States
Washington University School of Medicine
Saint Louis Missouri, 63110, United States
Siteman Cancer Center
Saint Peters Missouri, 63376, United States
John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC)
Hackensack New Jersey, 07601, United States
John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC)
Hackensack New Jersey, 07601, United States
Hackensack University Medical CenteR
Hackensack New Jersey, 07601, United States
John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC)
Hackensack New Jersey, 07601, United States
John Theurer Cancer Center, Hackensack University Medical Center
Hackensack New Jersey, 07601, United States
Memorial Sloan - Kettering Cancer Center
New York New York, 10065, United States
Penn State Milton S Hershey Medical Center
Hershey Pennsylvania, 17033, United States
UT Southwestern University Hospital - St. Paul
Dallas Texas, 75235, United States
Zale Lipshy University Hospital
Dallas Texas, 75235, United States
UT Southwestern Medical Center
Dallas Texas, 75390, United States
The University of Texas, M. D. Anderson Cancer Center
Houston Texas, 77030, United States
University of Texas, MD Anderson Cancer Center
Houston Texas, 77030, United States
Methodist Healthcare System of
San Antonio Texas, 78229, United States
University of Wisconsin Hospital and Clinics
Madison Wisconsin, 53792, United States
Pharmaceutical Research Center
Madison Wisconsin, 53792, United States
CHRU de Lille Hopital Claude Huriez
Lille , 59037, France
Institut Paoli Calmettes
Marseille , 13273, France
CHU Saint-Eloi
Montpellier Cedex 5 , 34295, France
Hopital Saint Louis
Paris , 75010, France
Hopital Haut-Leveque
Pessac , 33604, France
CH Lyon Sud
Pierre-Benite cedex 114 , 69495, France
CH Lyon Sud
Pierre-benite Cedex , 69495, France
Departement d'Hematologie et d'Oncologie-
Strasbourg , 67098, France
Charite Campus Virchow-Kilinikum-
Berlin , 13353, Germany
Samsung Medical Center
Seoul Gangnam-gu, 135-7, Korea, Republic of
Asan Medical Center
Seoul Seoul/korea, 138-7, Korea, Republic of
Severance Hospital, Yonsei University Health System
Seoul , 120-7, Korea, Republic of
Singapore General Hospital
Singapore , 16960, Singapore
Christie Hospital
Manchester , M20 4, United Kingdom
The Christie NHS Foundation Trust
Manchester , M20 4, United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 2

Estimated Enrollment:

64

Study ID:

NCT00867087

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Clinical Trials Test State-of-the-Art Cancer Treatments
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider